On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Jul. 2, 2020, the Centers for Disease Control and Prevention announced a publication in the journal Proceedings…
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 23, 2020, scientists at Scripps Research reported taht some common strains of influenza have the potential…
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 6, 2020, Predictive Oncology announced the acquisition of Soluble Therapeutics and partnership and licensing of a…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
On Apr. 27, 2020, BioAegis Therapeutics announced it had published gene expression data in animal studies where recombinant…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 15, 2020, FUJIFILM announced that it hds expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
On Apr. 9, 2020, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic H7N3 avian…
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
On Apr. 7, 2020, the FDA approved an Investigational New Drug application by Drug Innovation Ventures at Emory…
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsinï¾–Madison and the vaccine companies…
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent will provide molecule-to-market contract development…
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…